Hoa Nguyen-Thanh, Afzal Haroon, Doan Thu-Dung, Murtaza Asad, Yen Chia-Hung, Chung Yao-Chi
International Program in Animal Vaccine Technology, National Pingtung University Science and Technology, Pingtung 91201, Taiwan.
Department of Virology, National Institute of Veterinary Research NIVR, Hanoi 11500, Vietnam.
Vet Sci. 2025 Feb 18;12(2):181. doi: 10.3390/vetsci12020181.
The nuclear factor-kappa B (NF-κB) signaling pathway plays a crucial role in regulating immune responses in epithelial cells. In this study, we established a porcine epithelial NF-κB reporter cell line (PK15-KBR) as an in vitro platform to screen plant-based extracts for their potential use as vaccine adjuvants against porcine epidemic diarrhea virus (PEDV). The NF-κB inducers were further tested for toxicity assessments, either using CCK-8 assays or intramuscular injection in mice, finally followed by vaccination studies to evaluate their adjuvancy. Initial experiments confirmed that TNF-α effectively activated NF-κB signaling in PK15-KBR cells in a dose-dependent manner, validating the platform's reliability at Z' value of 0.68. Of the 224 testers, 3 candidates, including chamomile, mulberry and , showed induction activity; however, only chamomile induced a dose-dependent response in PK15-KBR cells. As a proof of concept, chamomile, used as an adjuvant in oral vaccination, demonstrated significantly higher IgG levels at an early stage (day 14, < 0.05) and enhanced IgA titers. These findings highlight the use of the PK15-KBR cell line in identifying mucosal adjuvants and position chamomile extract as a promising candidate for enhancing vaccine-induced immunity.
核因子-κB(NF-κB)信号通路在调节上皮细胞免疫反应中起关键作用。在本研究中,我们建立了一种猪上皮NF-κB报告细胞系(PK15-KBR)作为体外平台,以筛选植物提取物作为抗猪流行性腹泻病毒(PEDV)疫苗佐剂的潜在用途。进一步使用CCK-8试验或在小鼠中进行肌肉注射对NF-κB诱导剂进行毒性评估,最后通过疫苗接种研究来评估其佐剂活性。初步实验证实,TNF-α以剂量依赖性方式有效激活PK15-KBR细胞中的NF-κB信号,在Z'值为0.68时验证了该平台的可靠性。在224种测试物中,3种候选物,包括洋甘菊、桑椹等,显示出诱导活性;然而,只有洋甘菊在PK15-KBR细胞中诱导了剂量依赖性反应。作为概念验证,洋甘菊用作口服疫苗的佐剂,在早期(第14天)显示出显著更高的IgG水平(P<0.05)并提高了IgA滴度。这些发现突出了PK15-KBR细胞系在鉴定粘膜佐剂中的应用,并将洋甘菊提取物定位为增强疫苗诱导免疫的有前景的候选物。